Angiogenesis: Potentials for Pharmacologic Intervention in the Treatment of Cancer, Cardiovascular Diseases, and Chronic Inflammation

This publication has 216 references indexed in Scilit:

• Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1
  International Journal of Cancer, 1999
• Angiogenesis inhibitors overcome tumor induced endothelial cell anergy
  International Journal of Cancer, 1999
• ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin ?3
  Journal of Cellular Physiology, 1999
• Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity
  Journal of Cellular Physiology, 1998
• Angiogenic potential of malignant and non-malignant human breast tissues in anin vivo angiogenesis model
  International Journal of Cancer, 1998
• High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer
  International Journal of Cancer, 1998
• TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis
  International Journal of Cancer, 1998
• Targeting the tumor vasculature: Inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate
  International Journal of Cancer, 1997
• Expression of vascular endothelial growth factor in lymphomas and castleman's disease
  The Journal of Pathology, 1997
• Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells
  Journal of Cellular Physiology, 1996